The recombinant Pseudoalteromonas haloplanktis UPF0060 membrane protein PSHAa1175, hereafter referred to as PSHAa1175, is a protein derived from the bacterium Pseudoalteromonas haloplanktis. This protein is expressed in Escherichia coli and is fused with an N-terminal His tag for easier purification and identification. PSHAa1175 is a full-length protein consisting of 107 amino acids and is classified under the UPF0060 family of membrane proteins .
PSHAa1175 is a membrane protein, which suggests its involvement in various cellular processes such as signaling, transport, or structural support within the cell membrane. The specific function of PSHAa1175 in Pseudoalteromonas haloplanktis is not extensively documented, but its classification as a UPF0060 membrane protein indicates potential roles in membrane-related activities.
The recombinant form of PSHAa1175 is expressed in E. coli, which is a common host for recombinant protein production due to its well-understood genetics and efficient expression systems. The protein is purified to a high degree (>90%) as determined by SDS-PAGE, indicating its suitability for further biochemical studies .
| Characteristic | Description |
|---|---|
| Protein Length | Full Length (1-107 amino acids) |
| Expression Host | Escherichia coli |
| Tag | N-terminal His tag |
| Purity | >90% by SDS-PAGE |
| Storage Conditions | -20°C or -80°C |
| Reconstitution | Deionized sterile water, 0.1-1.0 mg/mL |
| Production System | Advantages | Disadvantages |
|---|---|---|
| Planktonic E. coli | Fast production, well-established protocols | May produce insoluble or proteolyzed proteins |
| Biofilm Pseudoalteromonas haloplanktis | Higher quality products, lower carbon source requirements | Slower production rate, less established protocols |
KEGG: pha:PSHAa1175
STRING: 326442.PSHAa1175
PSHAa1175 belongs to the UPF0060 family of membrane proteins found in Pseudoalteromonas haloplanktis. Most transmembrane proteins like PSHAa1175 typically traverse the lipid bilayer with their polypeptide chain forming regular α-helical structures, which maximizes hydrogen bonding between peptide bonds in the hydrophobic environment of the membrane . When investigating PSHAa1175, researchers should employ structural prediction methods such as hydropathy analysis to identify potential membrane-spanning regions, followed by experimental validation using techniques like circular dichroism or X-ray crystallography to confirm secondary structure elements.
As a membrane protein, PSHAa1175 presents unique experimental challenges compared to soluble proteins. The protein's integration within the lipid bilayer necessitates specialized extraction and purification protocols. Researchers should consider that membrane proteins can be arranged in different orientations – transmembrane proteins that cross the bilayer once or multiple times, or peripheral proteins that associate with membrane surfaces . The specific membrane localization of PSHAa1175 will determine appropriate detergent selection for solubilization, choice of expression systems, and purification strategies to maintain native structure and function.
For recombinant production of PSHAa1175, researchers should consider that membrane proteins often require specialized expression systems. Based on the cold-adapted nature of Pseudoalteromonas haloplanktis, low-temperature expression hosts may improve proper folding and functional yield. A methodological approach would involve:
Evaluating multiple expression systems (E. coli, yeast, insect cells, mammalian cells)
Testing various promoters and fusion tags to enhance solubility
Optimizing culture conditions (temperature, induction timing, media composition)
Comparing protein yield and functionality across systems
The optimal expression system should balance high yield with proper folding and post-translational modifications required for functional studies.
Membrane proteins like PSHAa1175 typically exist in multiple conformational states that may be functionally relevant. To distinguish between these states, researchers should employ a combination of:
Biophysical techniques: Circular dichroism (CD) spectroscopy, fluorescence spectroscopy, and nuclear magnetic resonance (NMR) can detect conformational changes under different conditions.
Functional assays: Develop assays specific to the hypothesized function of PSHAa1175 to correlate structural changes with activity.
Cross-linking studies: Chemical cross-linking coupled with mass spectrometry can capture transient interactions and conformational states.
Computational modeling: Molecular dynamics simulations can predict conformational transitions and stable states based on primary sequence data.
Different conformational states should be characterized under various conditions (pH, temperature, ligand binding) to establish a comprehensive conformational landscape relevant to the protein's function.
When faced with contradictory functional data for PSHAa1175, researchers should implement a systematic troubleshooting strategy:
Standardize experimental conditions across laboratories, including protein preparation methods, buffer compositions, and assay protocols.
Evaluate potential sources of variability:
Protein purity and integrity (verify by SDS-PAGE, mass spectrometry)
Lipid environment effects (test different lipid compositions)
Post-translational modifications (identify using mass spectrometry)
Presence of interacting partners (perform pull-down assays)
Conduct blind replications in multiple laboratories using identical protocols.
Implement orthogonal assays that measure the same function through different mechanisms to validate findings.
Resolution of contradictory data often requires systematic variance analysis to identify specific experimental factors contributing to discrepancies.
For studying PSHAa1175 interactions with the membrane environment, researchers should implement a multi-technique approach:
Reconstitution studies: Incorporate purified PSHAa1175 into artificial membrane systems (liposomes, nanodiscs) with varying lipid compositions to assess how lipid environment affects protein structure and function.
Fluorescence techniques: Utilize FRET (Förster Resonance Energy Transfer) or fluorescence anisotropy to measure protein-lipid interactions and protein dynamics within membranes.
Molecular dynamics simulations: Simulate PSHAa1175 behavior in different lipid environments to predict optimal conditions for functional studies.
Site-directed spin labeling: Introduce spin labels at specific sites to probe accessibility and conformational changes using electron paramagnetic resonance (EPR) spectroscopy.
The experimental design should account for the natural membrane environment of Pseudoalteromonas haloplanktis, which may have unique lipid compositions adapted to cold marine conditions.
Given that Pseudoalteromonas haloplanktis is a cold-adapted bacterium, temperature-dependent studies of PSHAa1175 are particularly relevant. An optimal experimental design would include:
Controlled temperature gradient experiments:
Systematically test protein stability and function across 0-37°C range
Monitor structural changes using CD spectroscopy at each temperature point
Correlate structural changes with functional assays
Kinetic analyses at different temperatures:
Measure reaction rates or binding kinetics at 4-5 different temperatures
Create Arrhenius plots to determine activation energies
Compare with mesophilic homologs to identify cold-adaptation features
Staggered experimental design:
The experimental design should include appropriate controls and statistical power calculations to detect temperature-dependent effects with confidence.
Purification of functional membrane proteins like PSHAa1175 requires specialized approaches:
| Purification Step | Method Options | Considerations for PSHAa1175 |
|---|---|---|
| Extraction | Detergent solubilization, Amphipol extraction | Mild detergents (DDM, LMNG) often preserve function better than harsh detergents (SDS) |
| Initial capture | IMAC, Affinity chromatography | His-tag or other fusion tags should be strategically placed to avoid functional regions |
| Intermediate purification | Ion exchange, Size exclusion | Buffer composition crucial; consider including stabilizing ligands |
| Final polishing | Size exclusion, Reverse phase | Assess protein homogeneity and detergent content |
| Quality control | SDS-PAGE, Mass spectrometry, Activity assays | Verify purity, integrity, and functional state |
For cold-adapted proteins like PSHAa1175, maintaining lower temperatures throughout purification may improve recovery of functional protein. The purification strategy should be validated by assessing both protein purity and retention of native function.
A comprehensive mutagenesis strategy for PSHAa1175 should include:
Sequence-based targeting:
Perform multiple sequence alignment with homologous proteins
Identify conserved residues as primary targets
Consider evolutionary conservation scores to prioritize mutations
Structure-based targeting:
If structural data is available, focus on residues in potential active sites
Target residues at predicted membrane interfaces
Examine predicted transmembrane regions and loops
Systematic approach options:
Alanine scanning: Replace continuous segments with alanine to identify functional regions
Conservative vs. non-conservative mutations: Compare effects of subtle vs. dramatic amino acid changes
Domain swapping: Exchange domains with homologous proteins to identify functional modules
Validation:
Express and purify each mutant under identical conditions
Perform parallel functional assays to quantitatively compare activities
Conduct structural analyses to confirm mutagenesis didn't disrupt global folding
This methodology ensures that mutagenesis studies yield interpretable data connecting specific residues to protein function.
For investigating post-translational modifications (PTMs) of PSHAa1175, researchers should implement this methodological approach:
Identification of potential PTMs:
Perform comprehensive mass spectrometry analysis of native and recombinant PSHAa1175
Compare PTM profiles across different expression systems
Use predictive algorithms to identify potential modification sites
Functional impact assessment:
Generate site-directed mutants at PTM sites (mimicking or preventing modification)
Compare functional parameters between wild-type and mutant proteins
Correlate PTM presence with subcellular localization using fluorescent tagging
Temporal dynamics:
Analyze modification patterns under different growth conditions
Track modifications through protein maturation and trafficking
Identify enzymes responsible for each modification using inhibitor studies or knockdown approaches
The membrane localization of PSHAa1175 may involve specific PTMs, similar to GPI anchors or lipid modifications seen in other membrane proteins , which could be critical for proper membrane integration and function.
Computational prediction of ligand binding sites in membrane proteins like PSHAa1175 requires specialized approaches:
Homology modeling:
Generate structural models based on homologous proteins of known structure
Validate models using energy minimization and Ramachandran plots
Compare multiple models from different templates for consensus regions
Binding site prediction algorithms:
Apply cavity detection algorithms (POCASA, FPocket)
Use evolutionary conservation mapping (ConSurf)
Implement molecular docking simulations with potential ligands
Molecular dynamics:
Perform long-timescale simulations to identify stable binding pockets
Analyze water and ion access to potential binding sites
Calculate binding energies for putative ligands
Validation:
Design experiments to test predictions (mutagenesis, binding assays)
Refine models based on experimental feedback
Implement multiple computational approaches and look for consensus predictions
Computational predictions should be treated as hypotheses requiring experimental validation, particularly for membrane proteins where structural information is often limited.
Integrating membrane protein function into systems biology frameworks requires specialized methodological approaches:
Interactome mapping:
Perform pull-down assays coupled with mass spectrometry
Use bacterial two-hybrid or membrane-specific yeast two-hybrid systems
Validate interactions with co-immunoprecipitation or FRET-based approaches
Network analysis:
Incorporate interaction data into protein-protein interaction networks
Identify functional clusters and pathway associations
Compare network positions of homologous proteins across species
Multi-omics integration:
Correlate PSHAa1175 expression levels with transcriptomic changes
Analyze metabolomic shifts in knockout or overexpression conditions
Map changes to known metabolic or signaling pathways
Mathematical modeling:
Develop kinetic models incorporating PSHAa1175 function
Use flux balance analysis to predict systemic effects of PSHAa1175 perturbation
Simulate condition-specific behaviors (temperature shifts, nutrient limitation)
This systems-level approach provides context for understanding PSHAa1175's role beyond its immediate function, potentially revealing unexpected relationships within the cellular network.